Research study Program year 2023 Source: CMS Open Payments

Gantenerumab Mild Ad

Research payments

$816,094

144 payments

Through program year 2023, $816,094 in research payments was reported against Gantenerumab Mild Ad, across 144 payments, paid by Genentech, Inc..

Paid by: Genentech, Inc.
ClinicalTrials.gov: No trial number was reported for this study

By program year

4 rows

Year	Kind	Amount	Payments
2023	Research	$3,260	1
2021	Research	$99,412	13
2020	Research	$277,164	53
2019	Research	$436,258	77

Breakdown

Who paid Research payments · program years 2019–2023

Genentech, Inc. $816,094 144 payments

Who received the money Research payments · program years 2019–2023

Compass Research North Organisation paid for research $151,405 14 payments
Neurology Clinic Pc MD Organisation paid for research $111,513 9 payments
Thomas M Shiovitz MD INC California Neuroscience Research Medical Group INC Organisation paid for research $72,021 16 payments
Tulsa Clinical Research LLC Organisation paid for research $64,150 4 payments
Senior Adults Specialty Research PA Organisation paid for research $59,480 9 payments
Pacific Research Network INC Organisation paid for research $57,203 27 payments
Central States Research LLC Organisation paid for research $56,764 5 payments
Michigan State University Organisation paid for research $47,090 9 payments
Miami Jewish Health Systems Inc Organisation paid for research $44,766 10 payments
University of South Florida Board of Trustees Organisation paid for research $39,873 13 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

10 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.